DrugPatentWatch Database Preview
Litigation Details for VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)
» See Plans and Pricing
VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)
Docket | Start Trial | Date Filed | 2015-04-14 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
Jury Demand | None | Referred To | Cathy L. Waldor |
Patents | 7,056,890; 7,553,818; 7,659,256; 7,674,776; 8,580,298; 8,580,299; 8,895,057; 8,895,058; 9,011,905; 9,011,906 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC.
Details for VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-06-17 | 14 | .S. Patent No. 7,056,890; (b) declaring that the claims of U.S. Patent No. 7,056,890 are … United States Patent Nos. 7,056,890 (the “’890 patent”), 7,553,818 (the “’818 patent”), 7,659,256 (the…United States Patent Nos. 7,056,890 (the “’890 patent”), 7,553,818 (the “’818 patent”), 7,659,256 (the…890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299 patent, the…890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299 patent, the | External link to document | |
2016-07-19 | 60 | claims in U.S Patent Nos. 7,056,890 (“the ’890 patent”), 7,553,818 (“the ’818 patent”), 7,659,256 (“…the ’299 patent, the ’057 patent, the ’058 patent, the ’905 patent, and the ’096 patent. Defendants …the ’890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299…299 patent, the ’057 patent, the ’058 patent, the ’905 patent, and the ’906 patent. 2. “topiramate…the ’890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299 | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |